Chemotaxis in cancer

Nature Reviews Cancer

Volumn 11, Issue 8, 2011, Pages 573-587

  Roussos, Evanthia T ^a   Condeelis, John S ^a   Patsialou, Antonia ^a  

^a YESHIVA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 3; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER THERAPY; CELL MIGRATION; CELL MOTION; CELL VIABILITY; CHEMOTAXIS; COLORECTAL CANCER; DRUG TARGETING; DUROTAXIS; ELECTROTAXIS; EPITHELIAL MESENCHYMAL TRANSITION; HAPTOTAXIS; HUMAN; IN VIVO STUDY; LUNG CARCINOMA; LYMPH NODE METASTASIS; MELANOMA; MESENCHYME CELL; METASTASIS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; STROMA CELL; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; PROGNOSIS; TUMOR CELLS, CULTURED;

EID: 79960790148     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3078     Document Type: Review

References (174)

1. Condeelis, J., Singer, R. H. & Segall, J. E. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 21, 695-718 (2005) (Pubitemid 41740651)
2. McSherry, E. A., Donatello, S., Hopkins, A. M. & McDonnell, S. Molecular basis of invasion in breast cancer. Cell. Mol. Life Sci. 64, 3201-3218 (2007)
3. Farrow, B., Albo, D. & Berger, D. H. The role of the tumor microenvironment in the progression of pancreatic cancer. J. Surg. Res. 149, 319-328 (2008)
4. Condeelis, J. & Segall, J. E. Intravital imaging of cell movement in tumours. Nature Rev. Cancer 3, 921-930 (2003) (Pubitemid 37500177)
5. Roussos, E. T. et al. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J. Cell Sci. 124, 2120-2131 (2011)
6. Petrie, R. J., Doyle, A. D. & Yamada, K. M. Random versus directionally persistent cell migration. Nature Rev. Mol. Cell Biol. 10, 538-549 (2009)
7. Provenzano, P. P., Eliceiri, K. W., Inman, D. R. & Keely, P. J. Engineering three-dimensional collagen matrices to provide contact guidance during 3D cell migration. Curr. Protoc. Cell Biol. 47, 10.17.1-10.17.11 (2010)
8. Raja, W. K., Gligorijevic, B., Wyckoff, J., Condeelis, J. S. & Castracane, J. A new chemotaxis device for cell migration studies. Integr. Biol. 2, 696-706 (2010)
9. Berthier, E., Surfus, J., Verbsky, J., Huttenlocher, A. & Beebe, D. An arrayed high-content chemotaxis assay for patient diagnosis. Integr. Biol. 2, 630-638 (2010)
10. Skoge, M. et al. Gradient sensing in defined chemotactic fields. Integr. Biol. 2, 659-668 (2010)
11. Bosgraaf, L., Keizer-Gunnink, I. & Van Haastert, P. J. PI3-kinase signaling contributes to orientation in shallow gradients and enhances speed in steep chemoattractant gradients. J. Cell Sci. 121, 3589-3597 (2008)
12. Patel, D. D. et al. Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99, 43-52 (2001)
13. Iglesias, P. A. & Devreotes, P. N. Navigating through models of chemotaxis. Curr. Opin. Cell Biol. 20, 35-40 (2008)
14. Friedl, P. & Wolf, K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 188, 11-19 (2010)
15. Sahai, E. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15, 87-96 (2005) (Pubitemid 40127636)
16. Smalley, K. S., Lioni, M. & Herlyn, M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell. Dev. Biol. Anim. 42, 242-247 (2006) (Pubitemid 44851881)
17. Gaggioli, C. et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature Cell Biol. 9, 1392-1400 (2007) (Pubitemid 350201752)
18. Rhee, S. Fibroblasts in three dimensional matrices: cell migration and matrix remodeling. Exp. Mol. Med. 41, 858-865 (2009)
19. Goswami, S. et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278-5283 (2005) (Pubitemid 40827339)
20. Kedrin, D. et al. Intravital imaging of metastatic behavior through a mammary imaging window. Nature Methods 5, 1019-1021 (2008)
21. Pinner, S. & Sahai, E. Imaging amoeboid cancer cell motility in vivo. J. Microsc. 231, 441-445 (2008)
22. Friedl, P. & Gilmour, D. Collective cell migration in morphogenesis, regeneration and cancer. Nature Rev. Mol. Cell Biol. 10, 445-457 (2009)
23. Wolf, K. et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277 (2003) (Pubitemid 36254960)
24. Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S. & Sahai, E. ROCK-and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 16, 1515-1523 (2006) (Pubitemid 44142977)
25. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009)
26. Nabeshima, K., Inoue, T., Shimao, Y. & Sameshima, T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52, 255-264 (2002) (Pubitemid 34587810)
27. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol. 5, 711-719 (2003) (Pubitemid 36986778)
28. Pankova, K., Rosel, D., Novotny, M. & Brabek, J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell. Mol. Life Sci. 67, 63-71 (2009)
29. Valentin, G., Haas, P. & Gilmour, D. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr. Biol. 17, 1026-1031 (2007) (Pubitemid 46899533)
30. Schmidt, M. et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 134, 2913-2923 (2007) (Pubitemid 47386904)
31. Lecaudey, V., Cakan-Akdogan, G., Norton, W. H. & Gilmour, D. Dynamic Fgf signaling couples morphogenesis and migration in the zebrafish lateral line primordium. Development 135, 2695-2705 (2008)
32. Haas, P. & Gilmour, D. Chemokine signaling mediates self-organizing tissue migration in the zebrafish lateral line. Dev. Cell 10, 673-680 (2006)
33. Aman, A. & Piotrowski, T. Wnt/β-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. Dev. Cell 15, 749-761 (2008)
34. Rorth, P. Collective guidance of collective cell migration. Trends Cell Biol. 17, 575-579 (2007) (Pubitemid 350138436)
35. Ilina, O. & Friedl, P. Mechanisms of collective cell migration at a glance. J. Cell Sci. 122, 3203-3208 (2009)
36. Wolf, K. et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nature Cell Biol. 9, 893-904 (2007) (Pubitemid 47190444)
37. Packard, B. Z., Artym, V. V., Komoriya, A. & Yamada, K. M. Direct visualization of protease activity on cells migrating in three-dimensions. Matrix Biol. 28, 3-10 (2009)
38. Clark, E. S., Whigham, A. S., Yarbrough, W. G. & Weaver, A. M. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67, 4227-4235 (2007) (Pubitemid 46815069)
39. Nabeshima, K. et al. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Cancer Res. 60, 3364-3369 (2000) (Pubitemid 30482147)
40. Friedl, P. & Wolf, K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res. 68, 7247-7249 (2008)
41. Farooqui, R. & Fenteany, G. Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J. Cell Sci. 118, 51-63 (2005) (Pubitemid 40277104)
42. Giampieri, S. et al. Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biol. 11, 1287-1296 (2009)
43. Kriebel, P. W., Barr, V. A. & Parent, C. A. Adenylyl cyclase localization regulates streaming during chemotaxis. Cell 112, 549-560 (2003) (Pubitemid 36263086)
44. Kriebel, P. W., Barr, V. A., Rericha, E. C., Zhang, G. & Parent, C. A. Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J. Cell Biol. 183, 949-961 (2008)
45. Li, S., Guan, J. L. & Chien, S. Biochemistry and biomechanics of cell motility. Annu. Rev. Biomed. Eng. 7, 105-150 (2005) (Pubitemid 41170186)
46. Devreotes, P. & Janetopoulos, C. Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J. Biol. Chem. 278, 20445-20448 (2003) (Pubitemid 36806338)
47. Veltman, D. M., Keizer-Gunnik, I. & Van Haastert, P. J. Four key signaling pathways mediating chemotaxis in Dictyostelium discoideum. J. Cell Biol. 180, 747-753 (2008) (Pubitemid 351397774)
48. Annesley, S. J. & Fisher, P. R. Dictyostelium discoideum-a model for many reasons. Mol. Cell. Biochem. 329, 73-91 (2009)
49. Swaney, K. F., Huang, C. H. & Devreotes, P. N. Eukaryotic chemotaxis: a network of signaling pathways controls motility, directional sensing, and polarity. Annu. Rev. Biophys. 39, 265-289 (2010)
50. Chung, C. Y., Funamoto, S. & Firtel, R. A. Signaling pathways controlling cell polarity and chemotaxis. Trends Biochem. Sci. 26, 557-566 (2001) (Pubitemid 32823441)
51. Janetopoulos, C. & Firtel, R. A. Directional sensing during chemotaxis. FEBS Lett. 582, 2075-2085 (2008)
52. King, J. S. & Insall, R. H. Chemotaxis: finding the way forward with Dictyostelium. Trends Cell Biol. 19, 523-530 (2009)
53. Jin, T. et al. How human leukocytes track down and destroy pathogens: lessons learned from the model organism Dictyostelium discoideum. Immunol. Res. 43, 118-127 (2009)
54. Zicha, D. et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101, 659-665 (1998) (Pubitemid 28308514)
55. Weiner, O. D. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr. Opin. Cell Biol. 14, 196-202 (2002) (Pubitemid 34219509)
56. Mouneimne, G. et al. Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr. Biol. 16, 2193-2205 (2006) (Pubitemid 44739276)
57. Desmarais, V. et al. N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil. Cytoskeleton 66, 303-316 (2009)
58. Wang, W., Eddy, R. & Condeelis, J. The cofilin pathway in breast cancer invasion and metastasis. Nature Rev. Cancer 7, 429-440 (2007) (Pubitemid 46809168)
59. van Rheenen, J., Condeelis, J. & Glogauer, M. A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J. Cell Sci. 122, 305-311 (2009)
60. Shields, J. D. et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526-538 (2007) (Pubitemid 46856909)
61. Ramjeesingh, R., Leung, R. & Siu, C. H. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J. 17, 1292-1294 (2003)
62. Reiland, J., Furcht, L. T. & McCarthy, J. B. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 41, 78-88 (1999) (Pubitemid 29446962)
63. Liu, Y. et al. Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 63, 210-218 (2009)
64. Liu, Z. & Klominek, J. Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors. Anticancer Res. 24, 1625-1630 (2004) (Pubitemid 38954686)
65. Tong, G. M., Rajah, T. T., Zang, X. P. & Pento, J. T. The effect of antiestrogens on TGF-β-mediated chemotaxis of human breast cancer cells. Anticancer Res. 22, 103-106 (2002) (Pubitemid 34475282)
66. Hayashibara, T. et al. Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. Clin. Cancer Res. 7, 2719-2726 (2001) (Pubitemid 32911376)
67. Bailly, M. et al. Epidermal growth factor receptor distribution during chemotactic responses. Mol. Biol. Cell 11, 3873-3883 (2000)
68. Hurst, J. H. & Hooks, S. B. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem. Pharmacol. 78, 1289-1297 (2009)
69. Insall, R. H. & Machesky, L. M. Actin dynamics at the leading edge: from simple machinery to complex networks. Dev. Cell 17, 310-322 (2009)
70. Hoeller, O. & Kay, R. R. Chemotaxis in the absence of PIP3 gradients. Curr. Biol. 17, 813-817 (2007) (Pubitemid 46635122)
71. Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540-550 (2004) (Pubitemid 38868623)
72. Murphy, P. M. Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345, 833-835 (2001)
73. Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56 (2001) (Pubitemid 32225831)
74. Lazennec, G. & Richmond, A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 16, 133-144 (2010)
75. Koshiba, T. et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 6, 3530-3535 (2000)
76. Balkwill, F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179 (2004) (Pubitemid 38586742)
77. Scotton, C. J. et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 62, 5930-5938 (2002) (Pubitemid 35204756)
78. Ghosh, M. et al. Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304, 743-746 (2004) (Pubitemid 38560882)
79. Oser, M. et al. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J. Cell Biol. 186, 571-587 (2009)
80. Van Goethem, E. et al. Macrophage podosomes go 3D. Eur. J. Cell Biol. 90, 224-236 (2011)
81. Price, L. S. & Collard, J. G. Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin. Cancer Biol. 11, 167-173 (2001) (Pubitemid 32423291)
82. Bravo-Cordero, J. J. et al. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr. Biol. 21, 635-644 (2011)
83. Sarmiento, C. et al. WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cells. J. Cell Biol. 180, 1245-1260 (2008) (Pubitemid 351468478)
84. Scott, R. W. et al. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J. Cell Biol. 191, 169-185 (2010)
85. DesMarais, V., Ghosh, M., Eddy, R. & Condeelis, J. Cofilin takes the lead. J. Cell Sci. 118, 19-26 (2005) (Pubitemid 40277101)
86. van Rheenen, J. et al. EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J. Cell Biol. 179, 1247-1259 (2007) (Pubitemid 350277742)
87. Miki, H., Yamaguchi, H., Suetsugu, S. & Takenawa, T. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 408, 732-735 (2000) (Pubitemid 32015990)
88. Abou-Kheir, W., Isaac, B., Yamaguchi, H. & Cox, D. Membrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2. J. Cell Sci. 121, 379-390 (2008) (Pubitemid 351356709)
89. Mader, C. C. et al. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res. 71, 1730-1741 (2011)
90. Weaver, A. M. et al. Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr. Biol. 11, 370-374 (2001) (Pubitemid 32200742)
91. Weaver, A. M. et al. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr. Biol. 12, 1270-1278 (2002) (Pubitemid 34869876)
92. Yoo, S. K. et al. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish. Dev. Cell 18, 226-236 (2010)
93. Andrew, N. & Insall, R. H. Chemotaxis in shallow gradients is mediated independently of PtdIns 3-kinase by biased choices between random protrusions. Nature Cell Biol. 9, 193-200 (2007) (Pubitemid 46420862)
94. Bailly, M., Yan, L., Whitesides, G. M., Condeelis, J. S. & Segall, J. E. Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells. Exp. Cell Res. 241, 285-299 (1998) (Pubitemid 28366554)
95. Falk, D. L. et al. Shared, unique and redundant functions of three members of the class I myosins (MyoA, MyoB and MyoF) in motility and chemotaxis in Dictyostelium. J. Cell Sci. 116, 3985-3999 (2003) (Pubitemid 37279313)
96. Chan, K. T., Bennin, D. A. & Huttenlocher, A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J. Biol. Chem. 285, 11418-11426 (2010)
97. Philippar, U. et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell 15, 813-828 (2008)
98. Neel, N. F. et al. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. J. Cell Sci. 122, 1882-1894 (2009)
99. Goswami, S. et al. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin. Exp. Metastasis 26, 153-159 (2009)
100. Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942-949 (2004) (Pubitemid 39273735)
101. Soria, G. & Ben-Baruch, A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285 (2008)
102. Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN. Cancer Cell 16, 183-194 (2009)
103. Sica, A. et al. Macrophage polarization in tumour progression. Semin. Cancer Biol. 18, 349-355 (2008)
104. Gu, L. et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411 (2000) (Pubitemid 30164344)
105. Tazzyman, S., Lewis, C. E. & Murdoch, C. Neutrophils: key mediators of tumour angiogenesis. Int. J. Exp. Pathol. 90, 222-231 (2009)
106. Pollard, J. W. Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 84, 623-630 (2008)
107. Sinha, P. et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181, 4666-4675 (2008)
108. Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nature Rev. Cancer 9, 239-252 (2009)
109. Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol. 9, 162-174 (2009)
110. Mantovani, A. et al. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21, 27-39 (2009)
111. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18 (2002)
112. Salcedo, R. et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J. Immunol. 166, 7571-7578 (2001) (Pubitemid 32525638)
113. Mehrad, B., Keane, M. P. & Strieter, R. M. Chemokines as mediators of angiogenesis. Thromb. Haemost. 97, 755-762 (2007) (Pubitemid 46804315)
114. Kryczek, I. et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65, 465-472 (2005)
115. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005) (Pubitemid 40692295)
116. Chen, H. et al. Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis. Blood 113, 1992-2002 (2009)
117. Nozawa, H., Chiu, C. & Hanahan, D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA 103, 12493-12498 (2006) (Pubitemid 44267286)
118. Ostman, A. & Augsten, M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr. Opin. Genet. Dev. 19, 67-73 (2009)
119. Ben-Baruch, A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 25, 345-356 (2008) (Pubitemid 351748979)
120. Koizumi, K., Hojo, S., Akashi, T., Yasumoto, K. & Saiki, I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 98, 1652-1658 (2007) (Pubitemid 47487897)
121. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563-572 (2002) (Pubitemid 37328923)
122. Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266 (2006) (Pubitemid 43121975)
123. Wyckoff, J. et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029 (2004) (Pubitemid 39331012)
124. Kacinski, B. M. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol. Reprod. Dev. 46, 71-74 (1997 (Pubitemid 27021356)
125. Patsialou, A. et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res. 69, 9498-9506 (2009)
126. Hernandez, L. et al. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin-β1 and CXCL12. Cancer Res. 69, 3221-3227 (2009)
127. Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649-2656 (2007) (Pubitemid 46548952)
128. Entenberg, D. et al. Set up and use of a two laser multiphoton microscope for multichannel intravital fluorescence imaging. Nature Protoc. doi:10.1038/nprot.2011.376 (2011)
129. Roussos, E. T. et al. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors. Breast Cancer Res. 12, R101 (2010)
130. Robinson, B. D. et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. Cancer Res. 15, 2433-2441 (2009)
131. Roussos, E. T. et al. Mena invasive (MenaINV) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Clin. Exp. Metastasis 12 Apr 2011 (doi:10.1007/s10585-011-9388-9386
132. Gerber, P. A., Hippe, A., Buhren, B. A., Muller, A. & Homey, B. Chemokines in tumor-associated angiogenesis. Biol. Chem. 390, 1213-1223 (2009)
133. Lurje, G. et al. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann. Oncol. 21, 78-86 (2009)
134. Wang, W. et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 64, 8585-8594 (2004) (Pubitemid 39552071)
135. Wang, W. et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res. 67, 3505-3511 (2007) (Pubitemid 46762128)
136. Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003) (Pubitemid 36808649)
137. Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005) (Pubitemid 41112921)
138. Ellis, L., Hammers, H. & Pili, R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 280, 145-153 (2009)
139. Miller, K. et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N. Engl. J. Med. 357, 2666-2676 (2007)
140. Hurwitz, H. Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin. Colorectal Cancer 4, S62-S68 (2004) (Pubitemid 39440145)
141. Huang, S. et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am. J. Pathol. 161, 125-134 (2002) (Pubitemid 34760778)
142. Mian, B. M. et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-κB. Clin. Cancer Res. 9, 3167-3175 (2003) (Pubitemid 36993279)
143. Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008) (Pubitemid 350309740)
144. Goss, P. E. & Chambers, A. F. Does tumour dormancy offer a therapeutic target? Nature Rev. Cancer 10, 871-877 (2010)
145. Kim, M. Y. et al. Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326 (2009)
146. Pantel, K. & Alix-Panabieres, C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol. Med. 16, 398-406 (2011)
147. Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781-791 (2004) (Pubitemid 39095313)
148. Cohen, S. J. et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann. Oncol. 20, 1223-1229 (2009)
149. Rack, B. K. et al. Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk of relapse: the SUCCESS trial. J. Clin. Oncol. 28 (Suppl.) Abstract 1003 (2010)
150. Sleeman, J. & Steeg, P. S. Cancer metastasis as a therapeutic target. Eur. J. Cancer 46, 1177-1180 (2010)
151. Steeg, P. S. Tumor metastasis: mechanistic insights and clinical challenges. Nature Med. 12, 895-904 (2006) (Pubitemid 44175140)
152. Wiegand, S., Kruse, J., Gronemann, S. & Hammann, C. Efficient generation of gene knockout plasmids for Dictyostelium discoideum using one-step cloning. Genomics 97, 321-325 (2011)
153. Koonce, M. P. & Graf, R. Dictyostelium discoideum: a model system for ultrastructural analyses of cell motility and development. Methods Cell Biol. 96, 197-216 (2010)
154. Williams, J. G. Dictyostelium finds new roles to model. Genetics 185, 717-726 (2010)
155. Whitney, T. J., Gardner, D. G., Mott, M. L. & Brandon, M. Identifying the molecular basis of functions in the transcriptome of the social amoeba Dictyostelium discoideum. Genet. Mol. Res. 9, 394-415 (2010)
156. van Hemert, F., Lazova, M. D., Snaar-Jagaska, B. E. & Schmidt, T. Mobility of G proteins is heterogeneous and polarized during chemotaxis. J. Cell Sci. 123, 2922-2930 (2010)
157. Stephens, L., Milne, L. & Hawkins, P. Moving towards a better understanding of chemotaxis. Curr. Biol. 18, R485-R494 (2008) (Pubitemid 351734644)
158. Alvarez-Curto, E. et al. cAMP production by adenylyl cyclase G induces prespore differentiation in Dictyostelium slugs. Development 134, 959-966 (2007) (Pubitemid 46795686)
159. Charest, P. G. et al. A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev. Cell 18, 737-749 (2010)
160. Cai, H. et al. Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J. Cell Biol. 190, 233-245 (2010)
161. Liu, L., Das, S., Losert, W. & Parent, C. A. mTORC2 regulates neutrophil chemotaxis in a cAMP-and RhoA-dependent fashion. Dev. Cell 19, 845-857 (2010)
162. Kay, R. R., Langridge, P., Traynor, D. & Hoeller, O. Changing directions in the study of chemotaxis. Nature Rev. Mol. Cell Biol. 9, 455-463 (2008) (Pubitemid 351733409)
163. Iglesias, P. A. Spatial regulation of PI3K signaling during chemotaxis. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 247-253 (2009)
164. Rericha, E. C. & Parent, C. A. Steering in quadruplet: the complex signaling pathways directing chemotaxis. Sci. Signal. 1, pe26 (2008)
165. Comer, F. I. & Parent, C. A. PI 3-kinases and PTEN: how opposites chemoattract. Cell 109, 541-544 (2002) (Pubitemid 34628717)
166. Funamoto, S., Meili, R., Lee, S., Parry, L. & Firtel, R. A. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109, 611-623 (2002) (Pubitemid 34628724)
167. Huang, Y. E. et al. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol. Biol. Cell 14, 1913-1922 (2003) (Pubitemid 36583542)
168. Hannigan, M. et al. Neutrophils lacking phosphoinositide 3-kinase-γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl Acad. Sci. USA 99, 3603-3608 (2002) (Pubitemid 34252153)
169. Loovers, H. M. et al. Distinct roles of PI(3,4,5)P3 during chemoattractant signaling in Dictyostelium: a quantitative in vivo analysis by inhibition of PI3-kinase. Mol. Biol. Cell 17, 1503-1513 (2006) (Pubitemid 44011571)
170. Yip, S. C. et al. The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration. J. Cell Sci. 120, 3138-3146 (2007)
171. Soon, L. L. A discourse on cancer cell chemotaxis: where to from here? IUBMB Life 59, 60-67 (2007) (Pubitemid 46535405)
172. Siegert, F. & Weijer, C. J. Three-dimensional scroll waves organize Dictyostelium slugs. Proc. Natl Acad. Sci. USA 89, 6433-6437 (1992
173. Killich, T. et al. The locomotion, shape and pseudopodial dynamics of unstimulated Dictyostelium cells are not random. J. Cell Sci. 106, 1005-1013 (1993 (Pubitemid 24018389)
174. Friedl, P., Borgmann, S. & Brocker, E. B. Amoeboid leukocyte crawling through extracellular matrix: lessons from the Dictyostelium paradigm of cell movement. J. Leukoc. Biol. 70, 491-509 (2001) (Pubitemid 32954760)